Delanson, NY, United States of America

Mark Allan Wolf



 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Denlanson, NY (US) (2015)
  • Delanson, NY (US) (2009 - 2022)
  • Williamsville, NY (US) (2017 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Mark Allan Wolf: Innovator in Pharmaceutical Compounds

Introduction

Mark Allan Wolf is a notable inventor based in Delanson, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work primarily focuses on compounds that have the potential to stimulate the immune system and treat various diseases.

Latest Patents

Among his latest patents, one is centered on indole compounds and their use in pharmaceutical compositions. This patent discusses the application of these compounds in stimulating the immune system of patients and in treating cancer. Another significant patent involves a dihydronaphthalene derivative, which has selective S1P5 receptor agonist activity. This compound is designed to treat S1P5-mediated diseases, including neurodegenerative conditions such as schizophrenia.

Career Highlights

Mark has worked with several companies throughout his career, including Ariagen, Inc. and Promentis Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Some of his notable coworkers include Peter Colabuono and Graham Johnson. Their collaboration has contributed to the advancement of research and development in the field of pharmaceuticals.

Conclusion

Mark Allan Wolf is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…